Larimar Therapeutics (LRMR) P/E (2014 - 2026)
Larimar Therapeutics (LRMR) P/E from Jun 30, 2014 to Jul 21, 2026. The TTM Larimar Therapeutics (LRMR) P/E is -1.96. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Larimar Therapeutics (LRMR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.96 | +12.02% |
| 2025 | -1.75 | -42.84% |
| 2024 | -3.06 | -48.24% |
| 2023 | -5.92 | +143.97% |
| 2022 | -2.43 | -30.93% |
| 2021 | -3.51 | -58.84% |
| 2020 | -8.53 | -60.35% |
| 2019 | -21.52 | -29.33% |
| 2018 | -30.45 | -1.03% |
| 2017 | -30.77 | +108.76% |
| 2016 | -14.74 | -46.55% |
| 2015 | -27.58 | -89.52% |
| 2014 | -263.12 | N/A |
Comparison Larimar Therapeutics (LRMR) P/E with competitors
Larimar Therapeutics (LRMR) P/E is -1.96.